Role of the sympathetic and renin angiotensin systems in the glucose-induced increase of blood pressure in rats

European Journal of Pharmacology

Volumn 506, Issue 2, 2004, Pages 143-150

  Villafaña, Santiago ^a   Huang, Fengyang ^a   Hong, Enrique ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Blood pressure; Glucose; Insulin; Renin angiotensin system; Sympathetic nervous system; Vasodilation

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; GLUCOSE; INDORENATE; INSULIN; MANNITOL; NITRIC OXIDE; RAMIPRIL; RENIN; RESERPINE; SODIUM CHLORIDE; STREPTOZOCIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; GLUCOSE; INSULIN; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 9944220556     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.055     Document Type: Article

References (48)

1. J.A. Beckman, A.B. Goldfine, M.B. Gordon, and M.A. Creager Ascorbate restore endothelium-dependent vasodilation impaired by acute hyperglycemia in humans Circulation 103 2001 1618 1623
2. 1 agonist Proc. West. Pharmacol. Soc. 34 1991 433 437
3. C.M. Boulanger, L. Caputo, and B.I. Lévy Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery Hypertension 26 1995 752 757
4. M.W. Brands, and T.E. Hopkins Poor glycemic control induces hypertension in diabetes mellitus Hypertension 27 3 Pt 2 1996 735 739
5. M.W. Brands, D.A. Hildebrandt, H.L. Mizelle, and J.E. Hall Sustained hyperinsulinemia increases arterial pressure in conscious rats Am. J. Physiol. 260 1991 R764 R768
6. H. Bruck, M. Gossl, R. Spitthover, R.F. Schafers, M. Kohnle, T. Philipp, and R.R. Wenzel The nitric oxide synthase inhibitor l-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine J. Hypertens. 19 2001 907 911
7. A. Ceriello, L. Quagliaro, M. D'Amico, C. Di Filippo, R. Marfella, F. Nappo, L. Berrino, F. Rossi, and D. Giugliano Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat Diabetes 51 2002 1076 1082
8. R.J. Cody The sympathetic nervous system and the renin-angiotensin- aldosterone system in cardiovascular disease Am. J. Cardiol. 80 9B 1997 9J 14J
9. L.X. Cubeddu, and I.S. Hoffmann Insulin resistance and upper-normal glucose levels in hypertension: a review J. Hum. Hypertens. 16 2002 S52 S55
10. M.D. Elliott, A. Kapoor, M.A. Parker, D.B. Kaufman, R.O. Bonow, and M. Gheorghiade Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation Circulation 104 2001 563 569
11. M. Epstein, and J.R. Sowers Diabetes mellitus and hypertension Hypertension 19 1992 403 418
12. T.C. Fang, and W.C. Huang Role of angiotensin II in hyperinsulinemia- induced hypertension in rats Hypertension 16 1998 1767 1774
13. J.H. Fuller Epidemiology of hypertension associated with diabetes mellitus Hypertension 7 6 Pt 2 1985 II3 II7
14. D. Giugliano, R. Marfella, L. Coppola, G. Verrazzo, R. Acampora, R. Giunta, F. Nappo, C. Lucarelli, and F. D'Onofrio Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia Circulation 95 1997 1783 1790
15. J. Gossmann, R. Burkhardt, S. Harder, T. Lenz, A. Sedlmeyer, U. Klinkhardt, T. Haak, H. Geiger, and E.H. Scheuermann Effect of angiotensin II infusion with and without angiotensin II type receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo controlled study in healthy volunteers Clin. Pharmacol. Ther. 68 2000 501 509
16. 15N]nitrate in biological fluids Anal. Biochem. 126 1982 131 138
17. ++ level and contraction in the rat aorta. Endothelium-dependent and -independent mechanisms Circ. Res. 77 1995 673 678
18. A.L. Hinderliter, and M.S. Runge Who's on first? Does hypertension in type I diabetes result from nephropathy or metabolic alterations? Circulation 104 2001 508 510
19. R.P. Hoffman, M. Hausberg, C.A. Sinkey, and E.A. Anderson Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans J. Diabetes its Complicat. 1 1999 17 22
20. E. Hong, R. Rión, and H. Vidrio Stimulation of central serotonin receptors as a novel mechanism of antihypertensive activity S. Shibata N. Toda K. Mohri Vascular Neuroeffector Mechanisms, 4th International Symposium 1983 Raven Press New York, NY 133 137
21. F. Huang, S. Villafaña, and E. Hong The role of the central and sympathetic nervous systems in the pressor effect of l-NAME J. Cardiovasc. Pharmacol. 41 2003 68 72
22. K. Jandeleit-Dahm, and M.E. Cooper Hypertension and diabetes Curr. Opin. Nephrol. Hypertens. 11 2002 221 228
23. H.L. Keen, M.W. Brands, M. Alonso-Galicia, and J.E. Hall Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats Am. J. Hypertens. 9 1996 1192 1199
24. A.E. Kitabchi, G.E. Umpierrez, M.B. Murphy, E.J. Barrett, R.A. Kreisberg, J.I. Malone, and B.M. Wall Management of hyperglycemic crises in patients with diabetes Diabetes Care 24 2001 131 153
25. A.S. Krolewski, M. Canessa, J.H. Warram, L.M. Laffel, A.R. Christlieb, W.C. Knowler, and L.I. Rand Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus N. Engl. J. Med. 318 1998 140 145
26. A. Makino, and K. Kamata Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats Diabetes Obes. Metab. 2 2000 47 55
27. K. Mather, T.J. Anderson, and S. Verma Insulin action in the vasculature: physiology and pathophysiology J. Vasc. Res. 38 2001 415 422
28. 1A and serotonin2 receptors in the central regulation of the cardiovascular system Pharmacol. Rev. 46 1994 231 241
29. J.A. Oates Antihypertensive agents and the drug therapy of hypertension A.G. Goodman The Pharmacological Basis of Therapeutics 1996 McGraw-Hill New York, NY 780 808
30. G.M. Pieper, D.A. Meier, and S.R. Hager Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia Am. J. Physiol. 269 1995 H845 H850
31. M.E. Pueyo, J.F. Arnal, J. Rami, and J.B. Michel Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells Am. J. Physiol. 274 1998 C214 C220
32. A.G. Ramage Central cardiovascular regulation and 5-hydroxytriptamine receptors Brain Res. Bull. 56 2001 425 439
33. G.M. Reaven Pathophysiology of insulin resistance in human disease Physiol. Rev. 75 1995 473 483
34. V.H. Routh Glucose-sensing neurons: are they physiologically relevant? Physiol. Behav. 76 2002 403 413
35. M.E. Safdy, E. Kurchacova, R.N. Schut, H. Vidrio, and E. Hong Tryptophan analogues: 1. Synthesis and antihypertensive activity of positional isomers J. Med. Chem. 25 1982 723 739
36. P.R. Saxena Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems J. Cardiovasc. Pharmacol. 19 Suppl. 6 1992 S80 S88
37. B.A. Schölkens, R.H.A. Becker, and J. Kaiser Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-l-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) Arzneim.-Forsch. 34 1984 1417 1425
38. J. Sorof, and S. Daniels Obesity hypertension in children. A problem of epidemic proportions Hypertension 40 2002 441 447
39. B. Tesfamariam, and R.A. Cohen Free radicals mediated endotelial cell dysfunction caused by elevated glucose Am. J. Physiol. 263 1992 H321 H326
40. B. Tesfamariam, M.L. Brown, and R.A. Cohen Elevated glucose impairs endothelium-dependent relaxations by activating protein kinase C J. Clin. Invest. 87 1991 1643 1648
41. B. Tesfamariam, M.L. Brown, and R.A. Cohen Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose J. Pharmacol. Exp. Ther. 263 1992 153 157
42. Y. Tomita, M. Ueno, T. Tsuchihashi, H. Muratani, S. Takishita, T. Kawasaki, K. Uezono, and M. Fujishima Sympathetic response to oral glucose load is altered in hypertensive subjects Clin. Exp. Hypertens., Part A Theory Pract. 11 Suppl. 1 1989 323 328
43. T. Unger, T. Fleck, D. Ganten, R.E. Lang, and F. Rettig 2-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-l-alanyl]-(1S,3S,5S)-2-azabicyclo[3. 3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats Arzneim.-Forsch. 34 1984 1426 1435
44. T. Walter, S. Heringer-Walther, R. Tschöpe, A. Reinecke, H. Schultheiss, and C. Tschöpe Opposite regulation of brain and C-type natriuretic peptides in the streptozotocin-diabetic cardiopathy J. Mol. Endocrinol. 24 2000 391 395
45. M.A. Weber, W.F. Graettinger, and D.G. Cheung Centrally acting sympathetic inhibitors J.H. Laragh B.M. Brenner Hypertension: Pathophysiology, Diagnosis, and Management 1990 Raven Press New York, NY 2251 2259
46. S.B. Williams, A.B. Goldfine, F.K. Timimi, H.H. Ting, M.A. Roddy, D.C. Simonson, and M.A. Creager Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo Circulation 97 1998 1695 1701
47. A. Yasuhara, T. Sugimoto, H. Naito, M. Yasuhara, and T. Matsumura Effects of hyperosmolality on the central nervous system and intracranial hemorrhage Brain Dev. 4 1982 353 360
48. I. Zavaroni, E. Bonora, M. Pagliara, E. Dall'Aglio, L. Luchetti, G. Buonanno, P.A. Bonati, M. Bergonzani, L. Gnudi, M. Passeri, and G. Reaven Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance N. Engl. J. Med. 320 1989 702 726